✉news HealthNutrition first seen 12 h ago, last 36 min ago, peak #3
Blood metabolites may predict triple-negative breast cancer risk
Original: Prospective analysis of pre-diagnostic untargeted plasma metabolomics and risk of triple-negative breast cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC)
Researchers with the International Agency for Research on Cancer have published a prospective analysis linking pre-diagnostic untargeted plasma metabolomics to the risk of triple-negative breast cancer, using data from the European Prospective Investigation into Cancer and Nutrition (EPIC). The study examines whether metabolic signatures measured before diagnosis can help identify women at higher risk of this aggressive cancer subtype.
Why now: The new EPIC-based study offers a potential route to earlier identification of triple-negative breast cancer, one of the hardest breast cancer subtypes to treat.
International Agency for Research on CancerEPICtriple-negative breast cancer
Rank over time, top of the chart is #1. 7 snapshots from 12 h ago to 36 min ago.
Evidence
- Prospective analysis of pre-diagnostic untargeted plasma metabolomics and risk of triple-negative breast cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC) · International Agency for Research on Cancer (IARC)
API: https://socialmediatrends-api.osmike.com/v1/trends/615614